good company and good peg well under 1
but heavy shorting and heavy discounting by competitors will hurt outlook.
as market leader, there is not much room for growth in aus beyond 2017
in china, outlook is good but growth may be solid rather than exponential
note china retail figures flat today.
ill stay on sidelines and if it hits 10.00 or sentiment turns shorters drop off ill buy, but i think shorters will hang around until the next report
i certainly would not sell as a holder, but this is not one for short term buy at these levels imho
- Forums
- ASX - By Stock
- BAL
- stock
stock, page-1117
-
-
- There are more pages in this discussion • 181 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BAL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online